About Bioduro
Bioduro is a company based in San Diego (United States) founded in 2005 was acquired by Advent International in January 2019. Bioduro has completed 1 acquisition, including Molecular Response. Bioduro operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, Personal Chemistry and NFIL, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
PPD
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Bioduro
Unlock access to complete
Unlock access to complete
Funding Insights of Bioduro
Detailed funding history for Bioduro
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bioduro
Bioduro has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include PPD and Advent International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
CRO providing diversified clinical development services
|
Locked | Locked | Locked |
Investor details for Bioduro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioduro
Bioduro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Molecular Response.
Investment portfolio details for Bioduro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specializes in biospecimen storage and tumor biobanking services.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Bioduro
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bioduro
Detailed financials for Bioduro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioduro Comparisons
Peer comparison for Bioduro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioduro
Bioduro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, Personal Chemistry and NFIL, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| Locked | Locked | Locked |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| Locked | Locked | Locked |
Phenoxazine and dihydrophenazine are manufactured by New Iridium.
|
Detailed competitors of Bioduro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioduro
Complete news archive for Bioduro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioduro
Bioduro was founded in 2005.
Bioduro is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
BioDuro was founded in 2005 in San Diego, United States, as a contract research, development, and manufacturing entity within the biopharmaceutical sector. Integrated services are delivered for drug discovery, encompassing compound synthesis and optimization across medicinal chemistry, biology, pharmacology, drug metabolism, pharmacokinetics, and safety evaluations. Operations extend to phase II-IV clinical management, data handling, biostatistics, cGMP production of drug products up to phase II, and clinical storage support.
Bioduro's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Bioduro has made 1 acquisition, including Molecular Response.
Bioduro has 2 investors. Key investors include PPD, and Advent International.